Back to rankings

Adtalem Global Education Inc. (ATGE)

NEGATIVE

Fundamental

~0

Price

$-

Market Cap

-

Part 1 · What the company is worth

Overview

Adtalem is a US for-profit higher-education company that owns and operates a group of universities: Chamberlain (nursing and health sciences), Walden (mostly graduate and doctoral programs, largely online) and a Medical and Veterinary group running Caribbean-based medical and veterinary schools. It does not build campuses to compete with state universities; instead it targets working adults and career-changers seeking a credential — nursing, counseling, medicine, veterinary science — tied directly to a licensed profession.

How it makes money

Revenue is tuition, paid mostly with US federal student loans and grants under Title IV of the Higher Education Act rather than out of pocket. Adtalem collects it per student per term across three university groups, so growth comes from enrolling more students, raising tuition, or improving how many stay enrolled to graduation. Because Title IV funding flows through the school, the business depends on staying accredited and meeting federal compliance rules that govern who can receive that aid.

Revenue by segment

Chamberlain University40.6%

Nursing and health-sciences degrees, mostly delivered online and at campuses aimed at working adults entering healthcare careers.

Walden University38.8%

Primarily online graduate and doctoral programs across fields such as counseling, education, public health and business.

Medical and Veterinary20.6%

Caribbean-based medical schools (Ross University, American University of the Caribbean) and a veterinary school training US-bound doctors and vets.

Competitive moat

Patents and licences · Narrow

A university cannot enroll students in aid-eligible programs without government-recognised accreditation and state authorization, and building a new accredited medical or nursing school from scratch takes years. That regulatory gate keeps new entrants out, but the same gate can be turned against Adtalem: losing accreditation or Title IV eligibility at any one school would cut off its funding just as fast.

What drives demand

Moderately cyclical

Enrollment depends on how many working adults want a career-focused credential and can get federal aid to pay for it, which is influenced by the broader job market and by former students' ability to repay their loans without defaulting — a link to the economy, but a less direct one than for cyclical consumer businesses.

Key risks

  • Dependence on Title IV federal student aid — Most revenue is collected through federal loan and grant programs; losing eligibility, even at one school, would cut off the funding that pays for most enrollment.
  • Accreditation and regulatory approval — Each school must keep its accreditation and state authorizations current; failing to maintain or renew any of them could force a school to stop enrolling students.
  • Cohort default rate limits — A school can lose Title IV eligibility if too many former students default on their loans, tying the business to graduates' employment and repayment outcomes.
  • Restrictions on recruitment compensation — Federal rules ban paying recruiters or admissions staff based on how many students they enroll, limiting how the company can incentivize growth.

The case for

Buyers argue that Adtalem's schools train students for licensed professions with structural shortages — nurses, doctors, vets — so demand is durable, that its programs mostly avoid brand-name university competition by serving working adults directly, and that regulatory barriers to opening a new accredited nursing or medical school protect its enrollment base.

The case against

Sellers worry that a business built on federal student aid is exposed to any tightening of Title IV rules or cohort default limits, that for-profit education carries reputational and political risk regardless of outcomes, and that a large share of revenue depends on students continuing to take on debt to pay for it.

Written by the editors, published on August 18, 2026

Direct competitors

Who this company fights with for the same customers

Compare

Generated on August 23, 2026 with claude-opus-5 — shared with all users

P/E: 17.9Score: 66Market cap: $3.92B

Through Grand Canyon University it recruits the same working adults for large-scale online and campus-based nursing and healthcare degrees that are Chamberlain's and Walden's core market.

P/E: 14.0Score: 63Market cap: $1.90B

Capella University and Strayer University compete head-on with Walden for online bachelor's, master's and doctoral students in nursing, education, psychology and business.

P/E: 12.0Score: 77Market cap: $2.10B

Colorado Technical University and American InterContinental University compete for the same online adult learners, and its University of St. Augustine for Health Sciences competes in graduate health-sciences and nursing degrees.

American Public Education, Inc.APEI

Rasmussen University and Hondros College of Nursing enroll pre-licensure ADN and practical-nursing students on campuses and online, the same pipeline Chamberlain's pre-licensure BSN targets.

St. George's UniversityNot tracked

A private Caribbean university in Grenada whose schools of medicine and veterinary medicine recruit the same US students seeking MD and DVM degrees abroad as Ross University and AUC.

Limited financial data available (0% of metrics). Scores may not accurately reflect this company's fundamentals.

Balance Sheet & Liquidity

Revenue

-

Net Income

-

Free Cash Flow

-

Total Equity

-

Total Liabilities

-

Current Ratio

0.82

Interest Coverage

-

Debt/EBITDA

-

Earnings Per Share

Revenue & Net Income

Free Cash Flow

Income Breakdown

Historical statement

Margins over time

Debt over time

How heavy the debt is

Growth grid

Growth — Revenue

Fair Value Estimation

N/A

Fair Value

$99.21

Current Price

-

Margin of Safety

-

Fair Value Range

$94.25 - $104.17

Estimation Methods

Analyst Target:-
DCF:-
PE-based:-
Graham Growth:-
EPV:$99.21

Valuation Metrics

P/E Ratio

13.43

ROE

17.8%

P/B Ratio

-

P/FCF

-

Gross Margin

-

ROIC

-

Profitability Radar

Value Creation (Economic Moat)

ROIC

-

WACC

8.0%

ROIC − WACC

-

Fundamental Analysis Criteria

Passed (0)

Failed (0)

Unavailable (1)

  • Error fetching data

Piotroski F-Score

-/9

Serious financial concerns

Earnings Quality

-

Low quality: investigate accounting

Share Dilution

-

Buying back shares. Shareholder friendly

Governance

Part 2 · The price and when to enter

This part won't tell you whether the company is worth owning: it helps you choose when to buy it, once the fundamentals have convinced you. Inside: technical analysis, potential, historical drawdowns, gamma exposure.

Latest News

Recent headlines for ATGE, sourced from Markets Gazette.

No recent news for ATGE.